Molecular Virology/Epidemiology Training in Kazakhstan (MoVE-Kaz) is a collaborative training program that includes key Kazakh institutions and is supported by United States and Belgian universities. Through MoVE-Kaz, early career scientists and clinicians will be trained in molecular epidemiology and HIV control.
The program will provide research and training opportunities in HIV and public health for scientists, researchers, academic medical school faculty, and government public health officials in Kazakhstan. It is a partnership between Nazarbayev University School of Medicine, Astana, Kazakhstan, and Yale University School of Public Health in New Haven CT, USA. Other key collaborating institutions are Asfendiyarov Kazakh National Medical University, Faculty of Public Health in Almaty; Katholieke Universiteit Leuven in Belgium; and State University of New York (SUNY)-Downstate, Brooklyn, NY, USA. The program MoVE-Kaz is funded by the Fogarty International Center of the U.S. National Institutes of Health.
The aims of the MoVE-Kaz program are to:
The goal of MoVE-Kaz is to train early-career Kazakhstani physicians and scientists in:
Topic areas for research theses may include population-based studies related to HIV treatment and prevention, viral hepatitis and other infections, with emphasis on molecular analyses.